| |
 |
|
复旦大学研究员，中华医学会微免分会青年委员，国际ISAC学会亚洲会员，《病毒学报》与《微生物感染与免疫》杂志编委。1997年毕业于中国医学科学院&中国协和医科大学并获博士学位，其后进入美国遗传与人类治疗研究所从事博士后工作；主要从事艾滋病疫苗和免疫学研究，先后建立和改进两种测定HIV特异性免疫T细胞方法,探索了一种新型的治疗策略（STI）,主持研发了艾滋病治疗性疫苗DermaVir的免疫原，此疫苗已在欧洲完成一期临床试验。2004年初回国开展工作，继续从事针对中国艾滋病毒流行株的疫苗研发、免疫策略探索、HIV/AIDS临床免疫学研究。申请美国专利两项：一项为新型的艾滋病治疗策略“间歇疗法”，另一项为治疗性疫苗DermaVir。主持的项目包括：国家“十五”科技攻关项目1项，美国NIH资助的大型研究项目2项，自然基金面上项目2项，科技部973子课题2项；发表研究论文50余篇，SCI杂志论文30篇，其中在Science发表论文一篇，影响因子5分以上杂志发表8篇。
代表论文——————————————————————————————
1. QIU Chao, XU Jianqing*.HIV/AIDS vaccine development: Are we in the darkness before the dawn? Chinese Medical Journal (Engl), in press. [Review]
2. Ruijun Zhang, Jianqing Xu，Kunxue Hong, Lin Yuan, Hong Peng, Pengfei Ma, Yuanzhi Zhang, Hui Xing, Yuhua Ruan, and Yiming Shao. NKG2A progressively increased in cytotoxic NK subset with the disease progression in HIV-1 infected individuals. AIDS, 2007, 21 (Suppl): s9-17
3. Xianggang Huang, Lianxing Liu, Li Ren, Chao Qiu, Yanmin Wan and Jianqing Xu*. Mucosal Priming with Replicative Tiantan Vaccinia and Systemic Boosting with DNA Vaccine Raised Strong Mucosal and Systemic HIV-specific Immune Responses. Vaccine, 2007, 25(52): 8874-84
4. Lianxing Liu, Yanmin Wan, Jianqing Xu*, Xianggang Huang, Lan Wu, Yong Liu, Yiming Shao. Immunogenicity Comparison between Codon Optimized HIV-1 CRF BC_07 gp140 and gp145 Vaccines. AIDS Research and Human Retrovirus, 23 (11): 1396-1404
5. Xianggang Huang, Jianqing Xu*, Chao Qiu, Li Ren, Lianxing Liu, Yanmin Wan, Ning Zhang, Hong Peng & Yiming Shao. Mucosal Priming with PEI/DNA Complex and Systemic Boosting with Recombinant TianTan Vaccinia Stimulate Vigorous Mucosal and Systemic Immune Responses. Vaccine, 2007, 25:2620-9
6. Jianqing Xu*, Li Ren, Xianggang Huang, Chao Qiu, Yong Liu, Ying Liu, Yiming Shao. Sequential Priming and Boosting with Heterologous HIV Immunogens Predominantly Stimulated T-cell Immunity against Conserved Epitopes. AIDS, 2006，20：2293-2303
7. Jianqing Xu*, Franco Lori and Julianna Lisziewicz. CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cells. Chinese Medical Journal, 2006，119: 1629-1638
8. Jianqing Xu, Lori F, Lisziewicz J. Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes. Journal of Immunological Methods, 276: 45-57, 2003
9. Jianqing Xu, Whitman L, Lori F, Lisziewicz J. Quantification of HIV-specific CD8+ T Cells by in vitro stimulation with inactivated viral particles. AIDS, 16: 1849-1857, 2002.
10. Lori F, Lewis M, Jianqing Xu, Lisziewicz J, et al. Control of SIV rebound through structured treatment interruptions during early infection. Science, 290: 1591~93, 2000.
|
|